Navigation Links
BioMarin Announces First Quarter 2011 Financial Results
Date:4/28/2011

$43 to $55Anticipated Upcoming Milestones2Q 2011: Initiation of pivotal Phase III trial for Firdapse for LEMS in the U.S.
3Q 2011: Top-line results from Phase II trial for PEG-PAL, including daily dosing and formulation studies
1Q 2012: Initiation of Phase III trial for PEG-PAL
1Q 2012: Initiation of Phase I trial for BMN-111 for Achondroplasia
1H 2012: 510k approval and commercial availability of the handheld blood Phe monitor for PKU
2H 2012: Top-line results for Phase III trial for GALNS for MPS IVA
2H 2012: Top-line results for PKU-016 Kuvan neurocognitive study
2H 2012: Top-line results for Phase I/II trial for BMN-701 for Pompe disease
4Q 2012/1Q 2013: Market authorization application filings for GALNS for MPS IVA

Research and Development ProgramsBioMarin continues to make significant investments in research and development to ensure persistent growth of the company.  The current pipeline includes programs in various stages of development that are focused on treating a range of serious unmet medical needs.Advanced Clinical Programs

  • GALNS for MPS IVA: BioMarin is enrolling patients in the randomized, double-blind, placebo-controlled Phase III study with primary endpoint of six-minute walk distance, 24 weeks in treatment duration and treatment doses of two mg/kg/week and two mg/kg/every other week.  The company expects to enroll approximately 160 patients across 40 centers worldwide and to report top-line results in the second half of 2012.
  • Kuvan Outcomes Study: PKU-016, a randomized, placebo-controlled, 13-week Kuvan outcomes study is ongoing.  Endpoints include clinically validated measures of neuropsychiatric symptoms and if successful, may enable a label amendment.  The company expects to report top-line results in the second half of 2012.
  • Hand-Held Blood Phe Monitor: Several programs are underway to expand and protect the market and to improve the abili
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
    2. BioMarin Announces FDA Approval for Kuvan
    3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
    4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
    5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
    6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
    7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    8. BioMarin to Present at the Oppenheimer Healthcare Conference
    9. BioMarin Announces Third Quarter 2009 Financial Results
    10. BioMarin to Acquire LEAD Therapeutics
    11. BioMarin to Present at the Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... 2014   Hospira, Inc. (NYSE: ... and infusion technologies, today announced that the company will ... on Wednesday, Jan. 14, 2015, in San Francisco.  ... at 10:30 a.m. Pacific time on Wednesday, Jan. 14, ... through a live audiocast accessible via the Investor Relations ...
    (Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
    (Date:12/19/2014)... , Dec. 18, 2014  Sage Analytics ... generation of equipment for the testing of marijuana ... of the new Luminary™ Profiler, the industry,s first ... measurement in a cost-effective, portable unit. ... specific needs of the cannabis industry, the Luminary™ ...
    Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
    ... Aug. 3 Omnicell, Inc ., (Nasdaq: ... system solutions to acute healthcare facilities, today released the new ... The next generation of packaging technology supports bar code medication ... accuracy. Integrated with the latest WorkflowRx software, version 7.0, this ...
    ... BEIJING , Aug. 3 ... LTUS ) ("Lotus" or the "Company"), ... in the People,s Republic of,China (the "PRC"), ... ingredient ("API") and tablets of R-Bambuterol for use in,clinical ...
    Cached Medicine Technology:Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 2Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 3Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency 4Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials 2Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials 3
    (Date:12/19/2014)... (PRWEB) December 20, 2014 The print ... Home and Business subscription of the Toronto Star, with ... readership of 622,169. The digital component is distributed nationally ... network of top news sites and partner outlets. To ... here . , The publication features an exclusive ...
    (Date:12/19/2014)... -- The intestinal bacteria that cause inflammatory bowel disease, ... inherited, researchers report. The findings, published recently in ... efforts to prevent the disease and treat the 1.6 ... added. "The intestinal bacteria, or ,gut microbiome, you ... big impact on your health for the rest of ...
    (Date:12/19/2014)... Potentially illness-causing E. coli bacteria were found on nearly ... a new study. Researchers checked cilantro, basil and ... in Los Angeles and Orange counties in California, and ... tested, 24 percent were positive for E. coli. One ... Both types of bacteria can cause sometimes serious ...
    (Date:12/19/2014)... 19, 2014 (HealthDay News) -- Dense bunches of bacteria called ... a new study finds. The researchers said these ... colon. The presence of these biofilms may represent an ... way to predict a person,s risk for the disease, the ... stones, these biofilms may coat the mucus layer of cells ...
    (Date:12/19/2014)... Older adults who have lost all their teeth have faster ... have at least some of their teeth, a new study ... provide an early warning of increased risk of physical and ... However, the findings don,t prove that tooth loss causes the ... 3,100 participants 60 and older. People with no remaining teeth ...
    Breaking Medicine News(10 mins):Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2
    ... of Public Health has awarded CNN anchor and special ... efforts while reporting on the devastating effects of Hurricane ... with the award at a ceremony at the Bloomberg ... O,Brien has shown the world tragedies of human conflict, ...
    ... by New Legislation , , ... (UBC) Annette Stemhagen, DrPH, FISPE, and Gerald Faich, MD, ... Summit held in Washington, DC, on October 28 and ... Jane Axelrad, Associate Director for Policy, CDER, FDA; Claudia ...
    ... group of consumers filed a proposed,nationwide class-action lawsuit earlier ... AG (FRA: BAY), alleging the pharmaceutical giant,skirted FDA requirements ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) , ... that Bayer markets two of its over-the-counter products --,Bayer ...
    ... Health plans today proposed guaranteed coverage for people with pre-existing ... , , Under the ... market would be required to offer coverage to all applicants ... individuals were required to maintain health insurance. , ...
    ... How is a Shortage of Primary Care Physicians Affecting the ... the American College of Physicians (ACP) documents the value of ... bibliography based on a literature review of more than 100 ... primary care in providing patients with better outcomes at lower ...
    ... they can raise long-term health risks, studies say , , ... poor caregiver relationships each increase levels of the stress ... two studies, published in the November/December issue of ... on children in these common situations. , Long-term or ...
    Cached Medicine News:Health News:Bloomberg School awards Goodermote Humanitarian Award to Soledad O'Brien 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 3Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 2Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 3Health News:Health Plans Propose Guaranteed Coverage for Pre-Existing Conditions and Individual Coverage Mandate 2Health News:Health Plans Propose Guaranteed Coverage for Pre-Existing Conditions and Individual Coverage Mandate 3Health News:Primary care provides patients with better outcomes at lower cost 2Health News:Child-Care Relationships Tied to Kids' Stress Levels 2Health News:Child-Care Relationships Tied to Kids' Stress Levels 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: